Bio-Techne (TECH) CEO exercises options; shares withheld for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bio-Techne Corp Chief Executive Officer Kim Kelderman reported routine equity compensation activity. On the reported date, he exercised stock options to acquire 26,692 shares of common stock at $47.60 per share, while 23,951 shares of common stock were withheld to cover tax obligations. After these transactions, he directly owned 89,750 common shares, and retained a substantial position in stock options and restricted stock units that remain outstanding.
Positive
- None.
Negative
- None.
Insider Trade Summary
26,692 shares exercised/converted
Mixed
19 txns
Insider
Kelderman Kim
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 26,692 | $0.00 | -- |
| Exercise | Common Stock | 26,692 | $47.60 | $1.27M |
| Tax Withholding | Common Stock | 23,951 | $56.68 | $1.36M |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Performance Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Performance Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 35,000 shares (Direct, null);
Common Stock — 89,750 shares (Direct, null);
Stock Options (Right to Buy) — 28,940 shares (Direct, null);
Performance Restricted Stock Units — 8,873 shares (Direct, null);
Performance Stock Options (Right to Buy) — 23,881 shares (Direct, null);
Restricted Stock Units — 17,087 shares (Direct, null)
Footnotes (1)
- Fully exercisable. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
Key Figures
Options exercised: 26,692 shares
Exercise price: $47.60/share
Tax-withheld shares: 23,951 shares
+5 more
8 metrics
Options exercised
26,692 shares
Stock options exercised into common stock at $47.60 per share
Exercise price
$47.60/share
Price for exercised stock options into common stock
Tax-withheld shares
23,951 shares
Shares withheld at $56.68 to satisfy tax obligations
Tax withholding price
$56.68/share
Value used for F-code tax-withholding disposition
Common shares after
89,750 shares
Direct Bio-Techne common stock held after transactions
Remaining options at $47.60
35,000 shares
Stock options (Right to Buy) expiring 2026-08-07
Largest option block
115,724 shares
Stock options at $66.97 expiring 2027-08-05
Long-dated options
90,441 shares
Options at $53.60 expiring 2035-08-15
Key Terms
Restricted Stock Units, Performance Restricted Stock Units, Performance Stock Options (Right to Buy), tax-withholding disposition, +2 more
6 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance Restricted Stock Units financial
"Vests in full or in part on 8/15/2026 if certain performance goals are achieved."
Performance restricted stock units (PRSUs) are promises to deliver company shares to employees or executives only if the business meets specific performance targets and any time-based holding rules. Think of them as a bonus that converts into stock only after set goals are reached, so investors watch PRSUs for two reasons: they can dilute existing shares if paid out, and they signal how closely management’s pay is tied to company performance.
Performance Stock Options (Right to Buy) financial
"Performance Stock Options (Right to Buy) with an exercise price of 68.5400."
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities."
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"Exercise or conversion of derivative security."
fully exercisable financial
"Fully exercisable."
FAQ
What insider activity did BIO-TECHNE (TECH) CEO Kim Kelderman report?
Kim Kelderman reported exercising stock options and related tax withholding. He exercised 26,692 stock options for Bio-Techne common shares and had 23,951 shares withheld to pay taxes, reflecting routine equity compensation activity rather than an open-market purchase or sale.
How many BIO-TECHNE (TECH) stock options did the CEO exercise and at what price?
Kim Kelderman exercised 26,692 stock options for Bio-Techne common stock at an exercise price of $47.60 per share. This option exercise converted a derivative award into directly held common shares as part of his existing long-term equity compensation package.
What derivative awards does the BIO-TECHNE (TECH) CEO still hold after this Form 4?
Kim Kelderman continues to hold several stock option and restricted stock unit awards. These include options over 35,000 shares at a $47.60 exercise price expiring in 2026 and multiple additional option and performance-based RSU grants with later vesting and expiration dates.